$2.67T
Total marketcap
$46.76B
Total volume
BTC 49.89%     ETH 17.07%
Dominance

Allied ALID Stock

0.18 USD {{ price }} 30.694546% {{change_pct}}%
Market Cap
18.52M USD
LOW - HIGH [24H]
0.12 - 0.18 USD
VOLUME [24H]
32.5K USD
{{ volume }}
P/E Ratio
0
Earnings per share
-0.1 USD

Allied Price Chart

Allied ALID Financial and Trading Overview

Allied stock price 0.18 USD
Previous Close 0.26 USD
Open 0.2 USD
Bid N/A x N/A
Ask N/A x N/A
Day's Range 0.2 - 0.28 USD
52 Week Range 0.1 - 0.7 USD
Volume 3.06K USD
Avg. Volume 8.43K USD
Market Cap 23.31M USD
Beta (5Y Monthly) 0.039961
PE Ratio (TTM) N/A
EPS (TTM) -0.1 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est N/A

ALID Valuation Measures

Enterprise Value 30.72M USD
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 121.005
Price/Book (mrq) N/A
Enterprise Value/Revenue 159.452
Enterprise Value/EBITDA -5.688

Trading Information

Allied Stock Price History

Beta (5Y Monthly) 0.039961
52-Week Change -45.39%
S&P500 52-Week Change 20.43%
52 Week High 0.7 USD
52 Week Low 0.1 USD
50-Day Moving Average 0.24 USD
200-Day Moving Average 0.3 USD

ALID Share Statistics

Avg. Volume (3 month) 8.43K USD
Avg. Daily Volume (10-Days) 2.97K USD
Shares Outstanding 97.04M
Float 61.24M
Short Ratio N/A
% Held by Insiders 53.29%
% Held by Institutions 0%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor 6.666:1

Financial Highlights

Fiscal Year

Fiscal Year Ends August 31, 2022
Most Recent Quarter (mrq) February 28, 2023
Next Fiscal Year End August 31, 2023

Profitability

Profit Margin 0%
Operating Margin (ttm) -2827.43%
Gross Margin 303.10%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) -58.10%
Return on Equity (ttm) N/A

Income Statement

Revenue (ttm) 192.67K USD
Revenue Per Share (ttm) 0.002 USD
Quarterly Revenue Growth (yoy) N/A
Gross Profit (ttm) 74.12K USD
EBITDA -5401205 USD
Net Income Avi to Common (ttm) -6519405 USD
Diluted EPS (ttm) -0.07
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 164.94K USD
Total Cash Per Share (mrq) 0.002 USD
Total Debt (mrq) 5.67M USD
Total Debt/Equity (mrq) N/A
Current Ratio (mrq) 0.212
Book Value Per Share (mrq) -0.021

Cash Flow Statement

Operating Cash Flow (ttm) -3559635 USD
Levered Free Cash Flow (ttm) -2528659 USD

Profile of Allied

Country United States
State BC
City Kelowna
Address 1405 St. Paul Street
ZIP V1Y 9N2
Phone N/A
Website https://allied.health
Industry Drug Manufacturers-Specialty & Generic
Sector(s) Healthcare
Full Time Employees N/A

Allied Corp., a medical cannabis production company, engages in the research, development, and production of cannabinoid health solutions in the United States. It offers hemp derived CBD natural health products, including Liberty, a hemp-derived cannabidiol (CBD) tincture; Tactical Hydration, a CBD infused electrolyte replacement drink; FIZZ Tablets for adding in a water bottle; Battle Balm, a CBD roll on activity rub for aches and pains; and Quick Hit, a CBD gummies under the Tactical Relief brand. The company also provides Hydrosport CBD Drink, a CBD infused electrolyte replacement drink with sodium citrate electrolyte replacement; Hydrosport Tincture, a CBD tincture fortified with specific terpene profile; FIZZ Tablets for adding to a water bottle; Sport Rub, a CBD post activity rub for aches and pains; and Quick Hit, a CBD gummies with vitamin B12 under the Equilibrium Bio brand. In addition, it offers Skin Structure, a facial formula topically applied to enhance skin's radiance and youthfulness; Eye Recover that helps the eye skin ward off free radicals, as well as helping to protect against sun damage; Glossy Lip Recover, which moisturizes and nourishes lips; Skin Designer that stimulates cell regeneration while minimizing age spots; Vitamin Absolute, a moisturizing facial oil; and Absolute Recover, a formulation that allows the infused bioactive compounds to be delivered directly to the desired areas of inflammation, pain, and other skin ailments under the MaXXa brand. In addition, it is developing ALID 10 and ALID 11, a pharma product, which is in Phase I clinical trial for treating post-traumatic stress disorder. The company was incorporated in 2013 and is headquartered in Kelowna, Canada.

Q&A For Allied Stock

What is a current ALID stock price?

Allied ALID stock price today per share is 0.18 USD.

How to purchase Allied stock?

You can buy ALID shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Allied?

The stock symbol or ticker of Allied is ALID.

Which industry does the Allied company belong to?

The Allied industry is Drug Manufacturers-Specialty & Generic.

How many shares does Allied have in circulation?

The max supply of Allied shares is 105.82M.

What is Allied Price to Earnings Ratio (PE Ratio)?

Allied PE Ratio is now.

What was Allied earnings per share over the trailing 12 months (TTM)?

Allied EPS is -0.1 USD over the trailing 12 months.

Which sector does the Allied company belong to?

The Allied sector is Healthcare.